Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JTC2 | ISIN: FR0011184241 | Ticker-Symbol: A89
Tradegate
27.06.25 | 16:00
3,810 Euro
+1,33 % +0,050
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ADOCIA SAS Chart 1 Jahr
5-Tage-Chart
ADOCIA SAS 5-Tage-Chart
RealtimeGeldBriefZeit
3,7453,77518:51
3,7453,77527.06.

Aktuelle News zur ADOCIA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiADOCIA Presentations at ADA & IPITA Scientific Conferences Highlight Scalability and Good Translation of AdoShell from Human Islets to Stem Cell-Derived Islets200Main results are: successful scale up from animal to human device for First-In-Human study in vitro and in vivo maturation after encapsulation of immature stem cell-derived islets in...
► Artikel lesen
12.06.ADOCIA SA: Number of Shares and Voting Rights of ADOCIA as of May 31st, 2025219Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French "Code de Commerce" and article 223-16 of the General Regulation of the French stock-market authorities (Autorité...
► Artikel lesen
22.05.ADOCIA Confirms its Eligibility for the PEA-PME Scheme308Regulatory News: Adocia (Euronext Paris: FR0011184241 ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment...
► Artikel lesen
21.05.ADOCIA Announces its Annual Shareholders' Meeting to be Held on June 11th, 2025 in Paris261Regulatory News: Adocia (Euronext Paris: FR0011184241 ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment...
► Artikel lesen
15.05.Number of Shares and Voting Rights of ADOCIA as of April 30th, 2025256Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French "Code de Commerce" and article 223-16 of the General Regulation of the French stock-market authorities (Autorité...
► Artikel lesen
ADOCIA Aktie jetzt für 0€ handeln
14.05.ADOCIA Reports First Quarter 2025 Financial Results and Provides a Business Update284Cash position of €12.2 million as of March 31, 2025, including €9.7m from the private placement successfully completed in February 2025 Cash runway extended until Q2 2026 Top-line...
► Artikel lesen
30.04.ADOCIA Announces the Release of its Universal Registration Document for the Year 2024261Regulatory News: Adocia (Euronext Paris: FR0011184241 ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment...
► Artikel lesen
28.04.ADOCIA to Present New Data on AdoShell at Upcoming Scientific Conferences - Showcasing Potential Curative Treatment for Type 1 Diabetes276Presentations demonstrate the potential of AdoShellfor allogenic cell therapy in diabetes without immunosuppression, by delivering pancreatic human islets or iPSCs1 New preclinical data support...
► Artikel lesen
17.04.ADOCIA Announces Full Year 2024 Financial Results and Provides a Corporate and Financial Update377Cash position of €7.5m (million) as of December 31, 2024, including: €2m received from private placement in March 2024 €9.8m from an equity financing line ("PACEO") with Vester Finance ...
► Artikel lesen
11.04.Number of Shares and Voting Rights of ADOCIA as of March 31st, 2025286Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French "Code de Commerce" and article 223-16 of the General Regulation of the French stock-market authorities (Autorité...
► Artikel lesen
14.03.Number of Shares and Voting Rights of ADOCIA as of February 28th, 2025284Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French "Code de Commerce" and article 223-16 of the General Regulation of the French stock-market authorities (Autorité...
► Artikel lesen
28.02.ADOCIA Announces the Settlement-Delivery of its €9.7 Million Private Placement733Regulatory News: NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN AND SOUTH AFRICA Adocia (Euronext Paris: FR0011184241 ADOC), a clinical-stage...
► Artikel lesen
26.02.Adocia raises €9.7 million in private placement, extending cash runway to Q2 20261
26.02.ADOCIA Announces the Successful Completion of a €9.7 Million Private Placement, Extending its Cash Runway to Q2 2026603Capital increase of a total amount of €9.7 million in gross proceeds by issuing a total number of 2,125,000 new shares, each with one share warrant attached, at €4.58 per share Gross Proceeds...
► Artikel lesen
25.02.ADOCIA Reports Fourth Quarter 2024 Financial Results and Provides a Business Update343Cash position of €7.5 million as of December 31, 2024 BioChaperone Lispro final dosing of Phase 3 triggered a $10 million revenue recognition, and top-line data are expected in mid-2025...
► Artikel lesen
14.02.Number of Shares and Voting Rights of ADOCIA as of January 31st, 2025280Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or...
► Artikel lesen
22.01.ADOCIA Announces Half-Year Report on Adocia's Liquidity Agreement with Kepler Capital Markets425Regulatory News: Under the liquidity agreement entrusted by Adocia (Euronext Paris: FR0011184241 ADOC) to Kepler Capital Markets, the following resources were listed on the liquidity account on...
► Artikel lesen
17.01.Number of Shares and Voting Rights of ADOCIA as of December 31st, 2024413Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or...
► Artikel lesen
23.12.24ADOCIA Announces Its Participation at Upcoming Investor Conferences in 2025422Regulatory News: Adocia (Euronext Paris: FR0011184241 ADOC, the "Company"), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions...
► Artikel lesen
19.12.24ADOCIA Announces its Financial Calendar for 2025375Regulatory News: Adocia (Euronext Paris: FR0011184241 ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment...
► Artikel lesen
Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1